Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2006 Jan 25;2006(1):CD004431.
doi: 10.1002/14651858.CD004431.pub2.

Psychological interventions for multiple sclerosis

Affiliations
Meta-Analysis

Psychological interventions for multiple sclerosis

P W Thomas et al. Cochrane Database Syst Rev. .

Abstract

Background: The unpredictable, variable nature of Multiple Sclerosis (MS), and the possibility of increasing disability, means that a diagnosis can have substantial psychological consequences.

Objectives: To assess the effectiveness of psychological interventions for people with MS.

Search strategy: We searched 19 databases up to December 2004; Cochrane MS Group Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, PsychINFO, CINAHL and 14 others. We searched reference lists of articles, wrote to corresponding authors of the 13 papers identified by June 2004, and searched for trials in progress using 3 research registers.

Selection criteria: Randomised controlled trials of interventions described as wholly or mostly based on psychological theory and practice, in people with MS. Primary outcome measures were disease specific and general quality of life, psychiatric symptoms, psychological functioning, disability, and cognitive outcomes. Secondary outcome measures were number of relapses, pain, fatigue, health care utilisation, changes in medication, and adherence to other therapies.

Data collection and analysis: Pertinent studies were identified from abstracts by one author. Full papers were independently compared to selection criteria by four authors. Key details were extracted from relevant papers using a standard format, and studies scored on three dimensions of quality. The review is organised into four mini-reviews (MR) dependent on the intervention's target population; people with cognitive impairments (MR1), people with moderate to severe disability (MR2), people with MS (no other criteria) (MR3), and people with depression (MR4).

Main results: Overall 16 studies were identified and included. MR1: three trials (n=145). Some evidence of effectiveness of cognitive rehabilitation on cognitive outcomes, although this was difficult to interpret because of the large number of outcome measures used. MR2: three trials (n=80). One small trial suggesting psychotherapy may help with depression. MR3: seven studies (n=688). Some evidence that cognitive behavioural therapy may help people adjust to, and cope with, having MS (three trials). The other trials were diverse in nature and some difficult to interpret because of multiple outcome measures. MR4: three trials (n=93). Two small studies of cognitive behavioural therapy showed significant improvements in depression.

Authors' conclusions: The diversity of psychological interventions identified indicates the many ways in which they can potentially help people with MS. No definite conclusions can be made from this review. However there is reasonable evidence that cognitive behavioural approaches are beneficial in the treatment of depression, and in helping people adjust to, and cope with, having MS.

PubMed Disclaimer

Conflict of interest statement

None

Update of

  • doi: 10.1002/14651858.CD004431

References

References to studies included in this review

Benedict 2000 {published data only}
    1. Benedict RHB, Shapiro A, Priore R, Miller C, Munschauer F, Jacobs L. Neuropsychological counseling improves social behavior in cognitively‐impaired multiple sclerosis patients. Multiple Sclerosis 2000;6:391‐6. - PubMed
Crawford 1985 {published data only}
    1. Crawford JD, McIvor GP. Group psychotherapy: Benefits in multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1985;66:810‐3. - PubMed
Foley 1987 {published data only}
    1. Foley FW, Bedell JR, LaRocca NG, Scheinberg LC, Reznikoff M. Efficacy of stress‐inoculation training in coping with multiple sclerosis. Journal of Consulting and Clinical Psychology 1987;55:919‐22. - PubMed
Gordon 1997 {published data only}
    1. Gordon PA, Lam CS, Winter R. Interaction strain and persons with multiple sclerosis: Effectiveness of a social skills program. Journal of Applied Rehabilitation Counselling 1997;28:5‐11.
Jonsson 1993 {published data only}
    1. Jonsson A, Korfitzen EM, Heltberg A, Ravnborg MH, Byskov‐Ottosen E. Effects of neuropsychological treatment in patients with multiple sclerosis. Acta Neurologica Scandinavica 1993;88:394‐400. - PubMed
Larcombe 1984 {published data only}
    1. Larcombe NA, Wilson PH. An evaluation of cognitive‐behaviour therapy for depression in patients with multiple sclerosis. British Journal of Psychiatry 1984;145:366‐71. - PubMed
Lincoln 2002 {published data only}
    1. Lincoln NB, Dent A, Harding J, Weyman N, Nicholl C, Blumhardt LD, et al. Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry 2002;72:93‐8. - PMC - PubMed
Maguire 1996 {published data only}
    1. Maguire, B. The effects of imagery on attitudes and moods in multiple sclerosis patients. Alternative Therapies 1996;2:75‐9. - PubMed
Mendoza 2001 {published data only}
    1. Mendoza RJ, Pittenger DJ, Weinstein CS. Unit management of depression of patients with multiple sclerosis using cognitive remediation strategies: A preliminary study. Neurorehabilitation and Neural Repair 2001;15:9‐14. - PubMed
Mohr 2000 {published data only}
    1. Mohr DC, Likosky W, Bertagnolli A, Goodkin DE, Wende J, Dwyer P, et al. Telephone‐administered cognitive behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. Journal of consulting and Clinical Psychology 2000;68(2):356‐61. - PubMed
Mohr 2001 {published data only}
    1. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive‐behavior therapy, supportive‐expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology 2001;69(6):942‐9. - PubMed
Mohr 2003 {published data only}
    1. Mohr DC, Hart SL, Goldberg A. Effects of treatment for depression on fatigue in multiple sclerosis. Psychosomatic Medicine 2003;65:542‐547. - PubMed
Rigby 2003 {published data only}
    1. Rigby, S. Coping with MS. Liverpool: University of Liverpool, 2003.
Schwartz 1999 {published data only}
    1. Schwartz CE. Teaching coping skills enhances quality of life more than peer support: Results of a randomised trial with multiple sclerosis patients. Health Psychology 1999;18:211‐20. - PubMed
Solari 2004 {published data only}
    1. Solari A, Motta A, Mendozzi L, Pucci E, Forni M, Mancardi G, Pozzilli C. Computer‐aided retraining of memory and attention in people with multiple sclerosis: a randomized, double‐blind controlled trial. Journal of the Neurological Sciences 2004;222:99‐104. - PubMed
Stuifbergen 2003 {published data only}
    1. Stuifbergen AK, Becker H, Blozis S, Timmerman G, Kullberg V. A randomized clinical trial of a wellness intervention for women with multiple sclerosis. Archives of Physical Medicine and Rehabilitation 2003;84:467‐76. - PubMed
Wassem 2003 {published data only}
    1. Wassem R, Dudley W. Symptom management and adjustment of patients with multiple sclerosis. Clinical Nursing Research 2003;12:102‐17. - PubMed

References to studies excluded from this review

Klarskov 1994 {published data only}
    1. Klarskov P, Heely E, Nyholdt I, Rottensten K, Nordenbo A. Biofeedback treatment of bladder dysfunction in multiple sclerosis. A randomised trial.. Scandanavian Journal of Urology and Nephrology 1994;Suppl. 157:61‐65. - PubMed
Mendozzi 1998 {published data only}
    1. Mendozzi L, Pugnetti L, Motta A, Barbieri E, Gambini A, Cazzullo CL. Computer‐assisted memory retraining of patients with multiple sclerosis. Italian Journal of Neurological Science 1998;19:S431‐8.
Mills 2000 {published data only}
    1. Mills N, Allen J. Mindfulness of movement as a coping strategy in multiple sclerosis. A pilot study. General Hospital Psychiatry 2000;22:425‐31. - PubMed
Mohr 2004 {published data only}
    1. Mohr DC, Classen C, Barrera M. The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Psychological Medicine 2004;34:533‐41. - PubMed
Rogers 1996 {published data only}
    1. Rogers D, Khoo K, MacEachen M, Oven M, Beatty WW. Cognitive therapy for multiple sclerosis: A preliminary Study. Alternative Therapies 1996;2(5):70‐4. - PubMed
Schmid 2004 {published data only}
    1. Schmid W, Aldridge D. Active music therapy in the treatment of multiple sclerosis patients: A matched control study. Journal of Music Therapy 2004;41:225‐40. - PubMed
Tesar 2003 {published data only}
    1. Tesar N, Baumhackl U, Kopp M, Gunther V. Effects of psychological group therapy in patients with multiple sclerosis. Acta Neurologica Scandinavica 2003;107:394‐9. - PubMed

References to studies awaiting assessment

Chiaravalloti 2005 {published data only}
    1. Chiaravalloti ND, DeLuca J, Moore NB, Ricker JH. Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial. Multiple Sclerosis 2005;11:58‐68. - PubMed
Mohr 2005 {published data only}
    1. Mohr DC, Cox D, Merluzzi N. Self‐injection anxiety training: a treatment for patients unable to self‐inject injectable medications. Multiple Sclerosis 2005;11:182‐5. - PubMed

References to ongoing studies

Mohr {published data only (unpublished sought but not used)}
    1. Telephone administered psychotherapy for the treatment of depression in multiple sclerosis. Personal Communication.
Moss‐Morris {published data only (unpublished sought but not used)}
    1. A randomised controlled trial of cognitive behavioural therapy for fatigue in patients with multiple sclerosis. Personal Communication.

Additional references

Aikens 1997
    1. Aikens JE, Fischer JS, Namey M, Rudick RA. A replicated prospective investigation of life stress coping and depressive symptoms in multiple sclerosis. Journal of Behavioral Medicine 1997;20:433‐45. - PubMed
Amato 1995
    1. Amato MP, Ponziani G, Pracucci G, Siracusa G, Amaducci L. Cognitive impairment in early‐onset multiple sclerosis. Archives of Neurology 1995;52:168‐72. - PubMed
Barnes 1954
    1. Barnes RH, Busse EW, Dinken H. The alleviation of emotional problems in multiple sclerosis by group therapy. Group Psychotherapy 1954;6:193‐201.
Barnwell 1997
    1. Barnwell AM, Kavanagh DJ. Prediction of psychological adjustment to multiple sclerosis. Social Science and Medicine 1997;45:411‐8. - PubMed
Bedford 1978
    1. Bedford A, Foulds G. Delusions‐Symptoms‐States‐Inventory. Windsor: NFER‐Nelson, 1978.
Bolding 1960
    1. Bolding H. Psychotherapeutic aspects in the management of patients with multiple sclerosis. Diseases of the Nervous System 1960;21:24‐6. - PubMed
Brassington 1998
    1. Brassington JC, Marsh NV. Neuropsychological aspects of multiple sclerosis. Neuropsychological Review 1998;8:43‐77. - PubMed
Clarke 2000
    1. Clarke M, Oxman AD. Cochrane Reviewer's Handbook Version 4.1.1 (updated December 2000); Section 6. The Cochrane Library. Oxford: Update Software, 2001, issue 1.
Crawford 1987
    1. Crawford JD, McIvor GP. Stress management for multiple sclerosis patients. Psychological Reports 1987;61:423‐429. - PubMed
Dalos 1983
    1. Dalos NP, Rabins PV, Brooks BR, O'Donnell P. Disease activity and emotional state in multiple sclerosis. Annals of Neurology 1983;13:573‐83. - PubMed
Day 1953
    1. Day M, Day E, Herman R. Group therapy of patients with multiple sclerosis. Archives of Neurology and Psychiatry 1953;69:193‐6. - PubMed
EuroQoL Group 1990
    1. EuroQoL Group. EuroQoL: a new facility for the measurement of health related quality of life. Health Policy 1990;16:199‐208. - PubMed
Fassbender 1998
    1. Fassbender K, Schmidt R, Mößner R, Kischka U, Kühnen J, Schwartz A, et al. Mood disorders and dysfunction of the hypothalamic‐pituitary‐adrenal axis in multiple sclerosis. Archives of Neurology 1998;55:66‐72. - PubMed
Feinstein 1999
    1. Feinstein A, O'Connor P, Gray T, Feinstein K. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Multiple Sclerosis 1999;5:323‐6. - PubMed
Franklin 1988
    1. Franklin GE, Heaton RK, Nelson LM, Filley CM, Seibert C. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology 1988;38:1826‐9. - PubMed
Gilchrist 1994
    1. Gilchrist AC, Creed FH. Depression, cognitive impairment and social stress in multiple sclerosis. Journal of Psychosomatic Medicine 1994;38:193‐201. - PubMed
Graham 2002
    1. Graham J. What is MS?. Multiple Sclerosis Society, UK. 2002:3.
Gulick 1997
    1. Gulick EE. Correlates among quality of life among persons with multiple sclerosis. Nursing Research 1997;46:305‐11. - PubMed
Hartings 1976
    1. Hartings MF, Pavlou MM, Davis FA. Group counseling of MS patients in a program of comprehensive care. Journal of Chronic Diseases 1976;29:65‐73. - PubMed
Heaton 1985
    1. Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM. Neuropsychological findings in relapse‐remitting multiple sclerosis. Journal of Consulting and Clinical Psychology 1985;53:103‐10. - PubMed
Hobart 2001
    1. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS‐29). A new patient‐based outcome measure. Brain 2001;124:962‐73. - PubMed
Joffe 1987
    1. Joffe RT, Lippert GP, Gray T, Sawa G, Horwath Z. Mood disorder and multiple sclerosis. Archives of Neurology 1987;44:376‐8. - PubMed
Kurtzke 1983
    1. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444‐52. - PubMed
Langdon 1996
    1. Langdon DW, Thompson AJ. Cognitive problems in multiple sclerosis. MS Management 1996;3:5‐9.
LaRocca 1993
    1. LaRocca NG, Kalb RC, Foley FW, Caruso LS. Assessment of psychosocial outcomes. Journal of Neurological Rehabilitation 1993;7:109‐16.
LaRocca 1996
    1. LaRocca NG, Ritvo PG, Miller DM, Fischer JS, Andrews H, Paty DW. "Quality of life" assessment in multiple sclerosis clinical trials: current status and strategies for improving multiple sclerosis clinical trial design. In: Goodkin DE, Rudick RA editor(s). Multiple sclerosis: advances in clinical trial design, treatment and future perspectives. London: Springer‐Verlag, 1996:145‐60.
Maurelli 1992
    1. Maurelli M, Marchioni E, Cerretano R, Bosone D, Bergamaschi R, Citterio A, et al. Neuropsychological assessment in MS: Clinical, neurophysiological and neuroradiological relationships. Acta Neurological Scandinavica 1992;86:124‐8. - PubMed
McIvor 1984
    1. McIvor GP, Riklan M, Reznikoff M. Depression in multiple sclerosis as a function of length and severity of illness, age, remissions and perceived social support. Journal of Clinical Psychology 1984;40:1028‐33. - PubMed
McNair 1981
    1. McNair DM, Lorr M, Droppleman LF. Profile of Mood States Manual. San Diego: Educational and Industrial Testing Service, 1981.
Miles 1979
    1. Miles A. Some psycho‐social consequences of multiple sclerosis: problems of social interaction and group identity. British Journal of Medical Psychology 1979;52:321‐31. - PubMed
Minden 1987
    1. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. General Hospital Psychiatry 1987;9:426‐34. - PubMed
Minden 1991
    1. Minden SL, Schiffer RB. Depression and mood disorders in multiple sclerosis. Neuropsychiatry 1991;4:62‐77.
Minden 1992
    1. Minden SL. Psychotherapy for people with multiple sclerosis. Neuropsychiatry 1992;4:198‐213. - PubMed
Minden 2000
    1. Minden SL. Mood disorders in multiple sclerosis: diagnosis and treatment. Journal of Neurovirology 2000;6 (Suppl 2):S160‐7. - PubMed
Moher 1998
    1. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352:609‐13. - PubMed
Mohr 1996
    1. Mohr DC, Goodkin DE, Likoksy W, Gatto N, Neilley LK, Griffen C, et al. Therapeutic expectations of patients with mutliple sclerosis upon initiating interferon beta‐1b: relationship to adherence to treatment. Multiple Sclerosis 1996;2:222‐6. - PubMed
Mohr 1997a
    1. Mohr DC, Goodkin DE, Gatto N, Wende J. Depression, coping, and level of neurological impairment in multiple sclerosis. Multiple Sclerosis 1997;3:254‐8. - PubMed
Mohr 1997b
    1. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann MA, Rudick RA. Treatment of depression improves adherence to interferon beta‐1b therapy for multiple sclerosis. Archives of Neurology 1997;54:531‐3. - PubMed
Mohr 1998
    1. Mohr DC, Likoksy W, Boudewyn AC, Marietta P, Dwyer P, Wende J, et al. Side effect profile and compliance in the treatment of multiple sclerosis with interferon beta‐1a. Multiple Sclerosis 1998;4:487‐9. - PubMed
Mohr 1999a
    1. Mohr DC, Likoksy W, Dwyer P, Wende J, Boudewyn AC, Goodkin DE. Course of depression during the initiation of interferon beta‐1a for multiple sclerosis. Archives of Neurology 1999;56:1263‐5. - PubMed
Mohr 1999b
    1. Mohr DC, Genain CP, Boudewyn AC. Relationship between treatment for depression and interferon‐gamma in patients with multiple sclerosis. Psychosomatic Medicine 1999;61:112. - PubMed
Mohr 1999c
    1. Mohr DC, Goodkin DE. Treatment of depression in multiple sclerosis: Review and meta‐analysis. Clinical Psychology: Science and Practice 1999;6:1‐9.
Mohr 2001a
    1. Mohr DC, Cox D. Multiple sclerosis: Empirical literature for the clinical health psychologist. Journal of Clinical Psychology 2001;57:479‐99. - PubMed
Mohr 2001b
    1. Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Treatment of depression is associated with suppression of non‐specific and antigen‐specific TH1 responses in multiple sclerosis. Archives of Neurology 2001;58:1081‐6. - PubMed
Mohr 2001c
    1. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive‐behavior therapy, supportive‐expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology 2001;69(6):942‐9. - PubMed
Mohr 2002
    1. Mohr DC, Goodkin DE, Nelson S, Cox D, Weiner M. Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosomatic Medicine 2002;64:803‐9. - PMC - PubMed
Mullins 2001
    1. Mullins LL, Cote MP, Fuemmeler BF, Jean VM, Beatty WW, Paul RH. Illness intrusiveness, uncertainty and distress in individuals with multiple sclerosis. Rehabilitation Psychology 2001;46(2):139‐53.
Nelson 1988
    1. Nelson LM, Franklin GM, Hamman RF, Boteler DL, Baum HM, Burks JS. Referral bias in multiple sclerosis research. Journal of Clinical Epidemiology 1988;41:187‐92. - PubMed
O'Brien 1993
    1. O'Brien MT. Multiple sclerosis: the relationship among self‐esteem, social support, and coping behaviour. Applied Nursing Research 1993;6:54‐63. - PubMed
Ostelo 2004
    1. Ostelo RWJG, Tulder MW van, Vlaeyen JWS, Linton SJ, Morley SJ, Assendelft WJJ. Behavioural treatment for chronic low back pain. Cochrane Database of Systematic Reviews 2004, Issue 3. [Art.No:CD002014. DOI:10.1002/14651858.CD002014.pub2] - PubMed
Pakenham 1997
    1. Pakenham KI, Stewart CA, Rogers A. The role of coping in adjustment to multiple sclerosis‐related adaptive demands. Psychology, Health and Medicine 1997;2:197‐211.
Pakenham 1999
    1. Pakenham KI. Adjustment to multiple sclerosis: Application of a stress and coping model. Health Psychology 1999;18:383‐92. - PubMed
Penman 1991
    1. Penman MF. Assessing the prevalence of cognitive impairment in multiple sclerosis: Implications for patient management. Axone 1991;13:45‐9. - PubMed
Pepper 1993
    1. Pepper CM, Krupp IB, Friedberg F, Doscher C, Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis and major depression. Journal of Neuropsychiatry and Clinical Neurosciences 1993;5:200‐5. - PubMed
Pfennings 1999
    1. Pfennings LE, Ploeg HM, Cohen L, Bramsen I, Polman CH, Lankhorst GJ, et al. A health related quality of life questionnaire for multiple sclerosis patients. Acta Neurologica Scandinavica 1999;100:148‐55. - PubMed
Pollock 1990
    1. Pollock SE, Christian BJ, Sands D. Responses to chronic illness: Analysis of psychological and physiological adaptation. Nursing Research 1990;39:300‐4. - PubMed
Poser 1983
    1. Poser CM, Paty DW, Scheinburg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research proposals. Annals of Neurology 1983;13:227‐31. - PubMed
Price 1998
    1. Price JR, Couper J. Cognitive behavioural therapy for chronic fatigue syndrome in adults. Cochrane Database of Systematic Reviews 1998, Issue 4. [Art. No: CD001027. DOI: 10.1002/14651858.CD001027] - PubMed
Prosiegal 1993
    1. Prosiegal M, Michael C. Neuropsychology and multiple sclerosis: diagnostic and rehabilitative approaches. Journal of the Neurological Sciences 1993;115(Suppl):S51‐4. - PubMed
Pujol 1997
    1. Pujol J, Bello J, Deus J, Marti‐Vilalta JL, Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 1997;49:1105‐10. - PubMed
Rabins 1986
    1. Rabins PV, Brooks BR, O'Donnell P, Pearlson GD, Moberg P. Structural correlates of emotional disorder in multiple sclerosis. Brain 1986;109:585‐97. - PubMed
Rao 1991
    1. Rao SM, Leo GJ, Bernadin L, Unversagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685‐91. - PubMed
Rao 1992
    1. Rao SM, Huber SJ, Bornstein RA. Emotional changes with multiple sclerosis and Parkinson's disease. Journal of Consulting and Clincial Psychology 1992;60:369‐78. - PubMed
Rosenberg 1965
    1. Rosenberg M. Self‐esteem scale. In: Rosenberg M editor(s). Society and the adolescent self‐image. Princeton, New Jersey: Princeton University Press, 1965.
Sadovnick 1991
    1. Sadovnick AD, Eisen K, Ebers GC, Paty DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991;41:1193‐6. - PubMed
Scheinberg 1984
    1. Scheinberg LC, Pfennings L, Pouwer F, Cohen L, Ketelaer P, Polman C, et al. Psychological functioning in primary progressive versus secondary progressive multiple sclerosis. British Journal of Medical Psychology 1998;71:99‐106. - PubMed
Schiaffino 1996
    1. Schiaffino KM, Shawaryn MS, Blum MA. Assessing the psychosocial impact of multiple sclerosis: learning from research on rheumatoid arthritis. Journal of Neurologic Rehabilitation 1996;10:81‐9.
Schiffer 1983
    1. Schiffer RB, Caine ED, Bamford KA, Levy S. Depressive episodes in patients with multiple sclerosis. American Journal of Psychiatry 1983;140:1498‐500. - PubMed
Schubert 1993
    1. Schuber DSP, Foliart RH. Increased depression in multiple sclerosis: a meta‐analysis. Psychosomatics 1993;34:124‐30. - PubMed
Schumacher 1965
    1. Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel of the evaluation of experimental trials in multiple sclerosis. Annals of the New York Academy of Sciences 1965;122:552‐68. - PubMed
Schwarzer 1995
    1. Schwarzer R, Jerusalem M. Generalised self‐efficacy scale. In: Weinman J, Wright S, Johnston M editor(s). Measures in health psychology: A user's portfolio. Windsor, UK: NFER‐Nelson, 1995.
Sharrack 1999
    1. Sharrack B, Hughs RA. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Multiple Sclerosis 1999;5:223‐33. - PubMed
Spitzer 1995
    1. Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JBW, Verloin deGruy III, et al. Health‐related quality of life in primary care patients with mental disorders. Results from the PRIME‐MD 1000 study. Journal of the American Medical Association 1995;274:1511‐7. - PubMed
Stenager 1994
    1. Stenager E, Knudsen L, Jensen K. Multiple sclerosis: Correlation of anxiety, physical impairment and cognitive dysfunction. Italian Journal of Neurological Science 1994;15:99‐103. - PubMed
Surridge 1969
    1. Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry 1969;115:749‐64. - PubMed
Thompson 1996
    1. Thompson AJ. Multiple sclerosis: symptomatic treatment. Journal of Neurology 1996;243:559‐65. - PubMed
Vickrey 1995
    1. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health‐related quality of life measure for multiple sclerosis. Qual Life Res 1995;4:187‐206. - PubMed
Walsh 1989
    1. Walsh A, Walsh PA. Love, self‐esteem and multiple sclerosis. Social Science and Medicine 1989;29:793‐8. - PubMed
Ware 1993
    1. Ware JE, Snow KK, Kosinski M, Gandek B. SF‐36 Health Survey manual and interpretation guide. Boston (MA): Nimrod Press, 1993.
Whitlock 1980
    1. Whitlock FA, Siskind MM. Depression as a major symptom of multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 1980;43:861‐5. - PMC - PubMed
Wilson 1999
    1. Wilson BA. Case studies in neuropsychological rehabilitation. New York: Oxford University Press, 1999.